Acupuncture for peripheral neuropathy induced by taxane based chemotherapy in breast cancer patients
Not Applicable
- Conditions
- taxane-induced peripheral neuropathy
- Registration Number
- DRKS00019215
- Lead Sponsor
- Interdisziplinäre Schmerzambulanz, Campus Innenstadt, Klinik für Anaesthesiologie, Klinikum der LMU München
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 56
Inclusion Criteria
peripheral neuropathy that had commenced during taxane-based (paclitaxel / docetaxel) chemotherapy (TIPN) for breast cancer,
Age at least 18 years,
chemotherapy completed
Exclusion Criteria
minority,
pregnancy or breastfeeding,
lack of German skills,
illiteracy,
lack of compliance,
chemotherapy with Paclitaxel/Docetaxel not completed,
diabetes mellitus,
other neuropathies besides TIPN,
acute or chronic pain conditions besides TIPN,
surgery in the last 3 months,
severe heart disease,
severe lung disease,
severe kidney disease,
severe neurological disease,
depression, schizophrenia, dementia,
other malignancies besides breast cancer,
severe skin alterations such as burns,
acupuncture of transcutaneous nerve stimulation within the last four weeks
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Baseline adjusted difference in the Neuropathic Pain Inventory (NPSI) between the ACU and the WL group at the time point after acupuncture and waiting time, respectively.
- Secondary Outcome Measures
Name Time Method